Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vascular disease
Phenotype |diabetes
Sentences 529
PubMedID- 22508698 Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
PubMedID- 22798707 In diabetes mellitus complicated by cardiovascular disease, insulin resistance and abnormal blood lipid concentrations play an important role.
PubMedID- 24616778 (6) attempted to demonstrate direct causation by examining cardiac innervation using metaiodobenzylguanidine imaging in patients with diabetes and no history of cardiovascular disease.
PubMedID- 21700920 Identifying and removing barriers to physical activity is important because of the strong relationship between physical inactivity and cardiovascular disease in people with type 2 diabetes and the likely cardiovascular benefits for people with type 1 diabetes (5,6).
PubMedID- 25927959 Background: hyperglycemia has been recognized as a primary factor in endothelial barrier dysfunction and in the development of micro- and macrovascular diseases associated with diabetes, but the underlying biochemical mechanisms remain elusive.
PubMedID- 24627825 Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus.
PubMedID- 25554536 Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
PubMedID- 25612994 We describe a concurrent manifestation of emphysematous pyelonephritis and ischaemic colitis in a 51-year-old diabetic woman and conclude that the colitis was due to pressure from a large retroperitoneal mass and sepsis complications combined with underlying peripheral vascular disease because of diabetes mellitus and hypertension.
PubMedID- 21359028 [28] although the metabolic syndrome unequivocally predisposes to type 2 diabetes mellitus,[29] many investigators of cardiovascular diseases consider this syndrome a multidimensional risk factor for ascvd.
PubMedID- 23166795 Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.
PubMedID- 26251229 Using an interrupted time series design and segmented regression, we estimated changes in monthly prescribing rates for thiazolidinediones among all and prevalent diabetes patients with and without cardiovascular disease history (cv history).
PubMedID- 25874615 Pre-diabetes is somewhat predictive of macrovascular diseases, but most of this association seems to be mediated through mets [4–6].
PubMedID- 25298426 These findings demonstrate that glp-1 as well as its analogs (glp-1-related reagents) may hold therapeutic potential in the treatment of diabetes with cardiovascular disease.
PubMedID- 25685383 Trends in the risk for cardiovascular disease among adults with diabetes in oman.
PubMedID- 23900314 Objectives: to provide a systematic and quantitative summary of the association between severe hypoglycaemia and risk of cardiovascular disease in people with type 2 diabetes and to examine the sensitivity of the association to possible uncontrolled confounding by unmeasured comorbid severe illness using a bias analysis.
PubMedID- 26083376 Pioglitazone has shown to have beneficial effect on cardiovascular diseases in patients with type 2 diabetes mellitus [18–20].
PubMedID- 25621136 The combination therapy of ppar-α and ppar-γ agonists led to a decrease in ldl-c levels, and might be of benefit in the treatment of type 2 diabetes patients with cardiovascular disease by downregulating cytokines37.
PubMedID- 26175995 Postprandial hyperglycemia performs the important function in the development of type 2 diabetes and complications associated with cardiovascular diseases.
PubMedID- 26177960 In contrast with the severe systemic vascular disease associated with diabetes, clinically relevant pulmonary vascular disease is uncommon in diabetics.
PubMedID- 22665334 As an example, cpgs for cardiovascular diseases in diabetes mellitus have been developed.24 these cpgs contain detailed practical instructions for management of cardiovascular diseases in diabetic patients.24 some studies have reported that cpgs can improve the health outcomes of patients in terms of in-hospital mortality or los and concluded that cpgs were a significant independent predictor of clinical outcomes of patients.25,26 therefore, we think that the preparation and institution of cpgs for bleeding peptic ulcers with comorbid diabetes mellitus would be a promising policy implementation for improving the short-term clinical outcomes of these patients.
PubMedID- 22994452 Regarding cardiovascular mortality, age, diabetes mellitus, history of cardiovascular disease, lvmi, lvef, cimt, and pwv were significant predictors (table2).
PubMedID- 21109113 Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the advance (action in diabetes and vascular disease: preterax and diamicron modified-release controlled evaluation) trial.
PubMedID- 26257973 This disorder is a rare complication of poorly controlled diabetes, usually occurring in patients with preexisting microvascular disease.
PubMedID- 24708826 **p-value from adjusted regression model where group was recognised and not recognised; adjusted variables were age, apache ii score, hypertension, diabetes and any type of vascular disease (reduced to two principal components in regression models).
PubMedID- 20195771 diabetes also is associated with microvascular disease and autonomic neuropathy; and, these non-coronary atherosclerotic pathophysiologic processes also have the potential to increase the risk of sca.
PubMedID- 24255692 Atorvastatin use may also result in the primary prevention of cardiovascular disease in patients with type ii diabetes (3).
PubMedID- 21517955 Post-meal hyperglycaemia is considered a risk factor for cardiovascular disease in patients with type 2 diabetes [1].
PubMedID- 23755276 Chronic hyperglycemia in diabetes is associated with cardiovascular disease and microvascular pathologies in the retina, kidney and peripheral nerves [1], [2].
PubMedID- 26100640 Nobody disputes the fact that type 1 diabetes increases the risk of death from cardiovascular diseases.
PubMedID- 24102059 Further data adjustment for age, gender, diabetes status, and history of past cardiovascular disease, dialysis vintage, and fmi did not substantially affect these results (table 5).
PubMedID- 20855550 Additionally, in order to reduce the high risk of cardiovascular disease in people with diabetes (24), a greater use of aspirin (1) has been encouraged.
PubMedID- 25923078 Type 2 diabetes mellitus patients with cardiovascular disease showed higher expression of plasma retinol binding protein and glutathione peroxidase-3 compared to those without cardiovascular disease and non-diabetic controls.
PubMedID- 26481300 Book review: diabetes in cardiovascular disease: a companion to braunwald's heart disease.
PubMedID- 24369540 Until now, most common additive risk factors for vascular disease in people with diabetes have been demonstrated as hyperglycaemia, insulin resistance, dyslipidaemia, hypertension, tobacco use, and obesity [2, 5]; however, the interaction of the factors and molecular signalling pathways have not been fully elucidated.
PubMedID- 25328404 Aim/introduction: circulating levels of n-terminal fragment of probrain natriuretic peptide (nt-probnp) are established as a risk factor for cardiovascular disease and mortality in patients with diabetes, as well as in the general population.
PubMedID- 23564913 In previous studies, statin therapy has been associated with a 19–55% reduction in cardiovascular disease events in patients with diabetes (33).
PubMedID- 26292807 Patients’ characteristics including metabolic co-morbidities and leucocyte counts as well as treatment characteristics are summarized in table 1. comorbidities included diabetes in 15.1 % of patients, cardiovascular disease in 34.6 % and hypertension in 45.7 %.
PubMedID- 25214836 Left ventricular hypertrophy (lvh) and albuminuria are both markers for cardiovascular diseases (cvds) in patients with type 2 diabetes mellitus (t2dm).
PubMedID- 26383851 [54] in taiwan, where they found a higher prevalence of vascular diseases associated with diabetes in females than in males.
PubMedID- 26473035 Moreover, microalbuminuria is associated with cardiovascular disease in patients with diabetes mellitus [7] and in the general population [8].
PubMedID- 24049653 It was determined in many multiple independent longitudinal studies that the hp genotype is an independent determinant of the risk of incident cardiovascular disease in individuals with diabetes mellitus (dm) [146–151].
PubMedID- 24404539 Clinically diagnosed diabetes mellitus with cardiovascular disease (dm+cvd) shall be the endpoint.
PubMedID- 20920303 If hypertension and chronic renal disease co-exist, as is common in patients with diabetes mellitus, the risk of cardiovascular disease is heightened.
PubMedID- 26318399 Association between cetp gene polymorphism, insulin resistance and risk of diabetes mellitus in patients with vascular disease.
PubMedID- 22389337 Since diabetes increases the risk of cardiovascular disease, for example, the impact of interventions for the treatment of hyperglycaemia in reducing this risk should be assessed.
PubMedID- 24476202 Participants with type 2 diabetes were free of clinical evidence of cardiovascular disease and renal involvement.
PubMedID- 22347652 The mechanisms underlying the increased risk of cardiovascular disease associated with diabetes mellitus (dm) are not fully defined.
PubMedID- 22194960 Individuals with pre-diabetes often bear clusters of cardiovascular disease risk factors [1].
PubMedID- 20601395 Methods and results: one hundred and fifty type 2 diabetes patients with cardiovascular disease (cvd) or >/= 1 other cvd risk factor were randomized to receive rosiglitazone vs.
PubMedID- 24654672 Whilst the number of deaths as a result of ketoacidosis or severe hypoglycaemia is lower than for cardiovascular disease in people with type 1 diabetes, these acute metabolic decompensations cause 9–13% of deaths in adults 1,2, with a higher proportion of 20–44% of deaths in children and young adults (excluding ketoacidosis at diagnosis) 1–5.

Page: 1 2 3 4 5 6 7 8 9 10 11